<pageurl page="0" url="http://www.opsi.gov.uk/si/si2000/20003231.htm"/>
<HTML><HEAD><TITLE>Statutory Instrument 
2000 No. 3231
</TITLE></HEAD><BODY bgcolor="#FFFFFF" LINK="#0000FF" VLINK="#990099" ALINK="#000000"><TABLE width=100%><TR><TD width=10%>&nbsp;</TD><TD><UL><UL><font size=+2>Statutory Instrument 2000 No. 3231</font><P><font size=+1><b>The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2000</b></font><p><HR><p>&copy; Crown Copyright 2000</p>

<P>
Statutory Instruments printed from this website are printed under the superintendence and authority of the Controller of HMSO being the Queen's Printer of Acts of Parliament.
<P>
The legislation contained on this web site is subject to Crown Copyright protection. It may be reproduced free of charge provided that it is reproduced accurately and that the source and copyright status of the material is made evident to users.
<P>
It should be noted that the right to reproduce the text of Statutory Instruments does not extend to the Queen's Printer imprints which should be removed from any copies of the Statutory Instrument which are issued or made available to the public. This includes reproduction of the Statutory Instrument on the Internet and on intranet sites. The Royal Arms may be reproduced only where they are an integral part of the original document.





<p>The text of this Internet version of the Statutory Instrument which is published by the Queen's Printer of Acts of Parliament has been prepared to reflect the text as it was Made. A print version is also available and is published by The Stationery Office Limited as the <b>The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2000</b>, ISBN 
0 11 018926 4.  The print version may be purchased by clicking <A HREF="/bookstore.htm?AF=A10075&FO=38383&ACTION=AddItem&ProductID=0110189264"> here</A>. Braille copies of this Statutory Instrument can also be purchased at the same price as the print edition by contacting TSO Customer Services on 0870 600 5522 or e-mail:<A HREF="mailto:customer.services@tso.co.uk">customer.services@tso.co.uk</A>.</p>


<P>
Further information about the publication of legislation on this website can be found by referring to the <A HREF="http://www.hmso.gov.uk/faqs.htm">Frequently Asked Questions</a>. 
<P>
To ensure fast access over slow connections, large documents have been segmented into "chunks". Where you see a "continue" button at the bottom of the page of text, this indicates that there is another chunk of text available.



</UL>

</UL></UL><HR><CENTER>
STATUTORY INSTRUMENTS</CENTER><HR>
<BR><CENTER><B><FONT size=4>
2000 No. 3231</FONT></B></CENTER><BR>
<CENTER><B><FONT size=4>
MEDICINES</FONT></B></CENTER><BR>
<CENTER><FONT size=4>
The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2000</FONT></CENTER><BR>
<TABLE width=100% cellpadding= 4>
<TR><TD width=10%>&nbsp;</TD><TD align=left width=40%><I>
Made</I></TD>
<TD align=right width=40%><I>8th December 2000</I></TD><TD width=10%>&nbsp;</TD></TR>
<TR><TD width=10%>&nbsp;</TD><TD align=left width=40%><I>
Laid before Parliament</I></TD>
<TD align=right width=40%><I>12th December 2000</I></TD><TD width=10%>&nbsp;</TD></TR>
<TR><TD width=10%>&nbsp;</TD><TD align=left width=40%><I>
Coming into force</I></TD>
<TD align=right width=40%><I>1st January 2001</I></TD><TD width=10%>&nbsp;</TD></TR>
</TABLE>
<BR>
As respects England, Scotland and Wales, the Secretary of State concerned with health in England, and, as respects Northern Ireland, the Minister of Health, Social Services and Public Safety, acting jointly, in exercise of the powers conferred upon them by sections 58(4) and (5) and 129(4) of the Medicines Act 1968[<a name="n1"><a href="#note1">1</A>] or, as the case may be, those conferred by the said provisions and now vested in them[<a name="n2"><a href="#note2">2</A>], and of all other powers enabling them in that behalf, after consulting such organisations as appear to them to be representative of interests likely to be substantially affected by this Order, pursuant to section 129(6) of that Act, and after consulting and taking into account the advice of the Committee on Safety of Medicines pursuant to sections 58(6) and 129(7) of that Act, and after taking into account the advice of the Medicines Commission pursuant to section 129(7) of that Act, hereby make the following Order&nbsp;-&nbsp;<BR><BR>
<B>
Citation, commencement and interpretation</B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;
<B>
<a name="1">1.</B>
&nbsp;-&nbsp;(1) This Order may be cited as the Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2000 and shall come into force on 1st January 2001.<BR><BR>
&nbsp;&nbsp;&nbsp;&nbsp;(2) In this Order, "the principal Order" means the Prescription Only Medicines (Human Use) Order 1997[<a name="n3"><a href="#note3">3</A>].<BR><BR>
<B>
Amendment of Schedule 1 to the principal Order</B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;
<B>
<a name="2">2.</B>
In Schedule 1 to the principal Order (which specifies substances which, if included in medicinal products, make those products prescription only medicines, and exemptions from the restrictions on the sale and supply of prescription only medicines), in relation to the substance Levonorgestrel, there are inserted the following entries&nbsp;-&nbsp;<BR><BR>
<UL>
in column 2&nbsp;-&nbsp;</UL><P>
<UL>
<UL>
" 
0.75mg"; and</UL><P>
</UL><P>
<UL>
in column 3&nbsp;-&nbsp;</UL><P>
<UL>
<UL>
" 
for use as an emergency contraceptive in women aged 16 years and over".</UL><P>
</UL><P>
<BR><I>Yvette Cooper</I><BR>
Parliamentary Under Secretary of State for Public Health, Department of Health<BR>
<BR>
4th December 2000<BR><BR>
<BR><I>Bairbre de Br&uacute;n</I><BR>
Minister of Health, Social Services and Public Safety<BR>
<BR>
8th December 2000<BR><BR>
<BR><HR><CENTER><B>
<a name="ex">EXPLANATORY NOTE
</B><BR><BR><I>
(This note is not part of the Order)</I></CENTER><BR><BR>
This Order amends Schedule 1 to the Prescription Only Medicines (Human Use) Order 1997 (which specifies substances which, if included in medicinal products, make them prescription only medicines, and exemptions from the restrictions in section 58(2) on sale and supply of prescription only medicines) to provide that medicinal products consisting of or containing Levonorgestrel may be sold or supplied otherwise than as a prescription only medicine provided that they are at a maximum strength of 0.75 mg and are sold or supplied exclusively for use as an emergency contraceptive in women aged 16 years and over.<BR><BR>
An assessment to the cost to business of complying with this Order has been made, copies of which have been placed in the libraries of both Houses of Parliament. Further copies may be obtained from the Department of Health, Medicines Control Agency, Information Centre, Room 10-202 Market Towers, 1 Nine Elms Lane, London SW8 5NQ.<BR><BR>
<HR><I>Notes:</I><BR><BR>
<a name="note1">
[1] 
1968 c. 67. The expression "the appropriate Ministers", and the expression "the Health Ministers" which is relevant to the powers being exercised in the making of this Order, are defined in section 1 of that Act as amended by article 2(2) of, and Schedule 1 to, S.I. 1969/388, and by article 5 of, and paragraph 1(1) of the Schedule to, S.I. 1999/3142; section 58 was amended by section 1 of the Prescription by Nurses etc. Act 1992 (c. 28).<a href="#n1">back</a><p>
<a name="note2">
[2] 
In the case of the Secretary of State concerned with health in England, by virtue of article 2(2) of, and Schedule 1 to, S.I. 1969/388, and articles 2(1) and 5 of, and paragraph 1(1) of the Schedule to, S.I. 1999/3142; and in the case of the Minister of Health, Social Services and Public Safety, by virtue of section 95(5) of, and paragraph 10 of Schedule 12 to, the Northern Ireland Act 1998 (c. 47).<a href="#n2">back</a><p>
<a name="note3">
[3] 
S.I. 1997/1830, amended by S.I. 1997/2044, 1998/108, 1178 and 2081, 1999/3463, 2000/1917 and 2899.<a href="#n3">back</a><p>
<P><HR>
<BR>
ISBN 
0 11 018926 4
<p>
<BR>
</TD><TD width=10%>&nbsp;</TD></TR></TABLE>
